BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 21747138)

  • 1. [Thymic abnormalities in patients with myasthenia gravis].
    Utsugisawa K; Nagane Y
    Brain Nerve; 2011 Jul; 63(7):685-94. PubMed ID: 21747138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myasthenia gravis.
    Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
    Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of the thymus in the physiopathology of myasthenia].
    Eymard B; Berrih-Aknin S
    Rev Neurol (Paris); 1995 Jan; 151(1):6-15. PubMed ID: 7676132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells.
    Sommer N; Willcox N; Harcourt GC; Newsom-Davis J
    Ann Neurol; 1990 Sep; 28(3):312-9. PubMed ID: 2241114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological aspects of malignant and benign thymic disorders.
    Müller-Hermelink HK; Marx A
    Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.
    Huang GZ; Lo YL
    J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of elevated CD4-/CD8- (double-negative) T cells after thymectomy parallels clinical remission in myasthenia gravis associated with thymic hyperplasia but not thymoma.
    Reinhardt C; Melms A
    Ann Neurol; 2000 Oct; 48(4):603-8. PubMed ID: 11026443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thymectomy on peripheral lymphocyte subsets in myasthenia gravis: selective effect on T-cells in patients with thymic atrophy.
    Haynes BF; Harden EA; Olanow CW; Eisenbarth GS; Wechsler AS; Hensley LL; Roses AD
    J Immunol; 1983 Aug; 131(2):773-7. PubMed ID: 6408188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
    Meinl E; Klinkert WE; Wekerle H
    Am J Pathol; 1991 Nov; 139(5):995-1008. PubMed ID: 1951638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the histological and immunohistochemical features of the thymus in young- and elderly-onset myasthenia gravis without thymoma.
    Ishii W; Matsuda M; Hanyuda M; Momose M; Nakayama J; Ehara T; Ikeda S
    J Clin Neurosci; 2007 Feb; 14(2):110-5. PubMed ID: 17113295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurofilament expression in thymic epithelial tumors and anti-axonal autoantibodies in myasthenia gravis: a model for autoimmunity by abnormal T cell selection].
    Marx A; Kirchner T; Greiner A; Schalke B; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1992; 76():256-61. PubMed ID: 1283271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of thymoma and thymic atrophy in patients with myasthenia gravis].
    Sund KK; Skeie GO; Gilhus NE; Aarli JA; Varhaug JE
    Tidsskr Nor Laegeforen; 1997 Nov; 117(29):4212-4. PubMed ID: 9441462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
    Hohlfeld R; Wekerle H
    J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymic lymphocytes in myasthenia gravis.
    Birnbaum G; Tsairis P
    Ann Neurol; 1977 Apr; 1(4):331-3. PubMed ID: 152595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
    Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
    J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients.
    Saito R; Onodera H; Tago H; Suzuki Y; Shimizu M; Matsumura Y; Kondo T; Itoyama Y
    J Neuroimmunol; 2005 Dec; 170(1-2):172-8. PubMed ID: 16214223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of miRNAs in Normal and Myasthenia Gravis Thymus.
    Cron MA; Guillochon É; Kusner L; Le Panse R
    Front Immunol; 2020; 11():1074. PubMed ID: 32587589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thymus in myasthenia gravis.
    Hohlfeld R; Wekerle H
    Neurol Clin; 1994 May; 12(2):331-42. PubMed ID: 8041345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.